25 XP   0   0   10

Medpace Holdings Inc
Buy, Hold or Sell?

Let's analyse Medpace together

PenkeI guess you are interested in Medpace Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medpace Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Medpace Holdings Inc

I send you an email if I find something interesting about Medpace Holdings Inc.

Quick analysis of Medpace (30 sec.)










What can you expect buying and holding a share of Medpace? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€17.07
Expected worth in 1 year
€22.46
How sure are you?
72.2%

+ What do you gain per year?

Total Gains per Share
€5.40
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
€369.80
Expected price per share
€284.50 - €382.50
How sure are you?
50%

1. Valuation of Medpace (5 min.)




Live pricePrice per Share (EOD)

€369.80

Intrinsic Value Per Share

€160.07 - €188.65

Total Value Per Share

€177.14 - €205.72

2. Growth of Medpace (5 min.)




Is Medpace growing?

Current yearPrevious yearGrowGrow %
How rich?$558.9m$406.1m$35.9m8.1%

How much money is Medpace making?

Current yearPrevious yearGrowGrow %
Making money$70.7m$61.3m$9.3m13.2%
Net Profit Margin15.0%16.8%--

How much money comes from the company's main activities?

3. Financial Health of Medpace (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#43 / 146

Most Revenue
#36 / 146

Most Profit
#31 / 146

What can you expect buying and holding a share of Medpace? (5 min.)

Welcome investor! Medpace's management wants to use your money to grow the business. In return you get a share of Medpace.

What can you expect buying and holding a share of Medpace?

First you should know what it really means to hold a share of Medpace. And how you can make/lose money.

Speculation

The Price per Share of Medpace is €369.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medpace.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medpace, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €17.07. Based on the TTM, the Book Value Change Per Share is €1.35 per quarter. Based on the YOY, the Book Value Change Per Share is €-3.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medpace.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps2.550.7%2.300.6%1.940.5%1.540.4%1.540.4%
Usd Book Value Change Per Share2.860.8%1.440.4%-3.51-0.9%1.010.3%1.010.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.860.8%1.440.4%-3.51-0.9%1.010.3%1.010.3%
Usd Price Per Share298.62-240.11-173.49-160.19-160.19-
Price to Earnings Ratio29.33-26.20-22.45-26.55-26.55-
Price-to-Total Gains Ratio104.34-50.13-56.92-71.99-71.99-
Price to Book Ratio16.43-16.77-14.43-9.87-9.87-
Price-to-Total Gains Ratio104.34-50.13-56.92-71.99-71.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share393.68908
Number of shares2
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.441.01
Usd Total Gains Per Share1.441.01
Gains per Quarter (2 shares)2.872.02
Gains per Year (2 shares)11.498.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011108-2
2023120166
30342302414
40463403222
50574504030
60695604838
70806705746
80927806554
901038907362
10011510008170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.00.00.0100.0%18.00.00.0100.0%18.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%13.05.00.072.2%13.05.00.072.2%13.05.00.072.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%13.05.00.072.2%13.05.00.072.2%13.05.00.072.2%

Fundamentals of Medpace

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Fundamental data was last updated by Penke on 2024-04-05 05:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Medpace Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medpace earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Medpace to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 15.7% means that €0.16 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medpace Holdings Inc:

  • The MRQ is 15.7%. The company is making a huge profit. +2
  • The TTM is 15.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.7%TTM15.0%+0.7%
TTM15.0%YOY16.8%-1.8%
TTM15.0%5Y15.4%-0.4%
5Y15.4%10Y15.4%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ15.7%-7.2%+22.9%
TTM15.0%-5.3%+20.3%
YOY16.8%0.9%+15.9%
5Y15.4%-3.4%+18.8%
10Y15.4%-1.4%+16.8%
1.1.2. Return on Assets

Shows how efficient Medpace is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medpace to the Diagnostics & Research industry mean.
  • 4.7% Return on Assets means that Medpace generated €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medpace Holdings Inc:

  • The MRQ is 4.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.7%TTM4.8%0.0%
TTM4.8%YOY4.6%+0.2%
TTM4.8%5Y3.6%+1.1%
5Y3.6%10Y3.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7%-1.8%+6.5%
TTM4.8%-1.3%+6.1%
YOY4.6%-0.4%+5.0%
5Y3.6%-0.6%+4.2%
10Y3.6%-1.3%+4.9%
1.1.3. Return on Equity

Shows how efficient Medpace is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medpace to the Diagnostics & Research industry mean.
  • 14.0% Return on Equity means Medpace generated €0.14 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medpace Holdings Inc:

  • The MRQ is 14.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 16.4%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.0%TTM16.4%-2.4%
TTM16.4%YOY16.1%+0.3%
TTM16.4%5Y9.8%+6.6%
5Y9.8%10Y9.8%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.0%-1.2%+15.2%
TTM16.4%-0.1%+16.5%
YOY16.1%0.4%+15.7%
5Y9.8%-1.7%+11.5%
10Y9.8%-2.5%+12.3%

1.2. Operating Efficiency of Medpace Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medpace is operating .

  • Measures how much profit Medpace makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medpace to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medpace Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM13.5%-13.5%
TTM13.5%YOY19.1%-5.5%
TTM13.5%5Y17.2%-3.7%
5Y17.2%10Y17.2%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.3%+4.3%
TTM13.5%-2.3%+15.8%
YOY19.1%4.8%+14.3%
5Y17.2%2.3%+14.9%
10Y17.2%-1.3%+18.5%
1.2.2. Operating Ratio

Measures how efficient Medpace is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.55 means that the operating costs are €1.55 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Medpace Holdings Inc:

  • The MRQ is 1.550. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.542. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.550TTM1.542+0.008
TTM1.542YOY1.513+0.029
TTM1.5425Y1.533+0.009
5Y1.53310Y1.5330.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5501.302+0.248
TTM1.5421.300+0.242
YOY1.5131.236+0.277
5Y1.5331.261+0.272
10Y1.5331.238+0.295

1.3. Liquidity of Medpace Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medpace is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.64 means the company has €0.64 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Medpace Holdings Inc:

  • The MRQ is 0.642. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.508. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.642TTM0.508+0.134
TTM0.508YOY0.454+0.054
TTM0.5085Y0.801-0.293
5Y0.80110Y0.8010.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6422.194-1.552
TTM0.5082.366-1.858
YOY0.4542.822-2.368
5Y0.8013.017-2.216
10Y0.8013.000-2.199
1.3.2. Quick Ratio

Measures if Medpace is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medpace to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.30 means the company can pay off €0.30 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medpace Holdings Inc:

  • The MRQ is 0.298. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.315. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.298TTM0.315-0.016
TTM0.315YOY0.319-0.005
TTM0.3155Y0.348-0.034
5Y0.34810Y0.3480.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2981.355-1.057
TTM0.3151.366-1.051
YOY0.3191.563-1.244
5Y0.3481.997-1.649
10Y0.3482.127-1.779

1.4. Solvency of Medpace Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medpace assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medpace to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.66 means that Medpace assets are financed with 66.3% credit (debt) and the remaining percentage (100% - 66.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medpace Holdings Inc:

  • The MRQ is 0.663. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.705. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.663TTM0.705-0.042
TTM0.705YOY0.696+0.008
TTM0.7055Y0.532+0.172
5Y0.53210Y0.5320.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6630.425+0.238
TTM0.7050.416+0.289
YOY0.6960.393+0.303
5Y0.5320.450+0.082
10Y0.5320.448+0.084
1.4.2. Debt to Equity Ratio

Measures if Medpace is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medpace to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 196.4% means that company has €1.96 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medpace Holdings Inc:

  • The MRQ is 1.964. The company is just able to pay all its debts with equity.
  • The TTM is 2.435. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.964TTM2.435-0.470
TTM2.435YOY2.541-0.106
TTM2.4355Y1.475+0.960
5Y1.47510Y1.4750.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9640.606+1.358
TTM2.4350.574+1.861
YOY2.5410.603+1.938
5Y1.4750.648+0.827
10Y1.4750.730+0.745

2. Market Valuation of Medpace Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Medpace generates.

  • Above 15 is considered overpriced but always compare Medpace to the Diagnostics & Research industry mean.
  • A PE ratio of 29.33 means the investor is paying €29.33 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medpace Holdings Inc:

  • The EOD is 38.666. Based on the earnings, the company is overpriced. -1
  • The MRQ is 29.329. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.201. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD38.666MRQ29.329+9.337
MRQ29.329TTM26.201+3.128
TTM26.201YOY22.446+3.754
TTM26.2015Y26.553-0.353
5Y26.55310Y26.5530.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD38.666-0.295+38.961
MRQ29.329-0.518+29.847
TTM26.201-0.156+26.357
YOY22.446-0.003+22.449
5Y26.5531.627+24.926
10Y26.5536.427+20.126
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medpace Holdings Inc:

  • The EOD is 20.678. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.685. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.448. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.678MRQ15.685+4.993
MRQ15.685TTM19.448-3.763
TTM19.448YOY18.929+0.518
TTM19.4485Y18.006+1.441
5Y18.00610Y18.0060.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD20.678-0.284+20.962
MRQ15.685-0.382+16.067
TTM19.448-1.074+20.522
YOY18.929-2.055+20.984
5Y18.006-2.492+20.498
10Y18.006-2.411+20.417
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medpace is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 16.43 means the investor is paying €16.43 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Medpace Holdings Inc:

  • The EOD is 21.665. Based on the equity, the company is expensive. -2
  • The MRQ is 16.434. Based on the equity, the company is expensive. -2
  • The TTM is 16.769. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD21.665MRQ16.434+5.232
MRQ16.434TTM16.769-0.335
TTM16.769YOY14.434+2.335
TTM16.7695Y9.869+6.900
5Y9.86910Y9.8690.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD21.6651.960+19.705
MRQ16.4342.449+13.985
TTM16.7692.225+14.544
YOY14.4343.239+11.195
5Y9.8693.393+6.476
10Y9.8693.897+5.972
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Medpace Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.6881.349+99%-3.296+223%0.948+184%0.948+184%
Book Value Per Share--17.06913.499+26%11.929+43%17.526-3%17.526-3%
Current Ratio--0.6420.508+26%0.454+41%0.801-20%0.801-20%
Debt To Asset Ratio--0.6630.705-6%0.696-5%0.532+24%0.532+24%
Debt To Equity Ratio--1.9642.435-19%2.541-23%1.475+33%1.475+33%
Dividend Per Share----0%-0%-0%-0%
Eps--2.3912.159+11%1.818+32%1.443+66%1.443+66%
Free Cash Flow Per Share--4.4713.029+48%2.633+70%2.175+106%2.175+106%
Free Cash Flow To Equity Per Share--4.5171.634+176%-2.992+166%0.211+2042%0.211+2042%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--188.654--------
Intrinsic Value_10Y_min--160.072--------
Intrinsic Value_1Y_max--10.958--------
Intrinsic Value_1Y_min--10.759--------
Intrinsic Value_3Y_max--38.981--------
Intrinsic Value_3Y_min--37.092--------
Intrinsic Value_5Y_max--74.305--------
Intrinsic Value_5Y_min--68.447--------
Market Cap11374789140.000+24%8627983650.0006937375623.750+24%5158063522.350+67%4964483686.717+74%4964483686.717+74%
Net Profit Margin--0.1570.150+5%0.168-7%0.154+2%0.154+2%
Operating Margin---0.135-100%0.191-100%0.172-100%0.172-100%
Operating Ratio--1.5501.542+1%1.513+2%1.533+1%1.533+1%
Pb Ratio21.665+24%16.43416.769-2%14.434+14%9.869+67%9.869+67%
Pe Ratio38.666+24%29.32926.201+12%22.446+31%26.553+10%26.553+10%
Price Per Share369.800+24%280.500225.538+24%162.963+72%150.472+86%150.472+86%
Price To Free Cash Flow Ratio20.678+24%15.68519.448-19%18.929-17%18.006-13%18.006-13%
Price To Total Gains Ratio137.553+24%104.33650.126+108%56.923+83%71.994+45%71.994+45%
Quick Ratio--0.2980.315-5%0.319-7%0.348-14%0.348-14%
Return On Assets--0.0470.048-1%0.046+3%0.036+30%0.036+30%
Return On Equity--0.1400.164-15%0.161-13%0.098+43%0.098+43%
Total Gains Per Share--2.6881.349+99%-3.296+223%0.948+184%0.948+184%
Usd Book Value--558938139.081442036619.784+26%406126381.815+38%634770529.884-12%634770529.884-12%
Usd Book Value Change Per Share--2.8621.436+99%-3.509+223%1.010+184%1.010+184%
Usd Book Value Per Share--18.17114.371+26%12.699+43%18.658-3%18.658-3%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--2.5452.298+11%1.935+32%1.536+66%1.536+66%
Usd Free Cash Flow--146405893.20199179395.369+48%87790887.038+67%67236850.982+118%67236850.982+118%
Usd Free Cash Flow Per Share--4.7603.224+48%2.803+70%2.315+106%2.315+106%
Usd Free Cash Flow To Equity Per Share--4.8091.740+176%-3.186+166%0.225+2042%0.225+2042%
Usd Market Cap12109600518.444+24%9185351393.7907385530089.044+24%5491274425.894+67%5285189332.879+74%5285189332.879+74%
Usd Price Per Share393.689+24%298.620240.107+24%173.490+72%160.193+86%160.193+86%
Usd Profit--78296338.51670700999.693+11%61340698.323+28%50510039.265+55%50510039.265+55%
Usd Revenue--498390423.931471450495.608+6%364991254.721+37%325563313.622+53%325563313.622+53%
Usd Total Gains Per Share--2.8621.436+99%-3.509+223%1.010+184%1.010+184%
 EOD+4 -4MRQTTM+26 -7YOY+25 -85Y+21 -1210Y+21 -12

3.2. Fundamental Score

Let's check the fundamental score of Medpace Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1538.666
Price to Book Ratio (EOD)Between0-121.665
Net Profit Margin (MRQ)Greater than00.157
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.298
Current Ratio (MRQ)Greater than10.642
Debt to Asset Ratio (MRQ)Less than10.663
Debt to Equity Ratio (MRQ)Less than11.964
Return on Equity (MRQ)Greater than0.150.140
Return on Assets (MRQ)Greater than0.050.047
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Medpace Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.084
Ma 20Greater thanMa 50368.790
Ma 50Greater thanMa 100353.466
Ma 100Greater thanMa 200309.928
OpenGreater thanClose374.800
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  -777-32-809-474-1,2831,184-991,8311,732



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,656,828
Total Liabilities1,097,878
Total Stockholder Equity558,950
 As reported
Total Liabilities 1,097,878
Total Stockholder Equity+ 558,950
Total Assets = 1,656,828

Assets

Total Assets1,656,828
Total Current Assets593,828
Long-term Assets1,063,000
Total Current Assets
Cash And Cash Equivalents 245,449
Net Receivables 275,932
Other Current Assets 49,979
Total Current Assets  (as reported)593,828
Total Current Assets  (calculated)571,360
+/- 22,468
Long-term Assets
Property Plant Equipment 265,390
Goodwill 662,396
Intangible Assets 35,809
Long-term Assets Other 24,970
Long-term Assets  (as reported)1,063,000
Long-term Assets  (calculated)988,565
+/- 74,435

Liabilities & Shareholders' Equity

Total Current Liabilities925,131
Long-term Liabilities172,747
Total Stockholder Equity558,950
Total Current Liabilities
Accounts payable 31,869
Other Current Liabilities 40,441
Total Current Liabilities  (as reported)925,131
Total Current Liabilities  (calculated)72,310
+/- 852,821
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt142,122
Long-term Liabilities Other 28,221
Long-term Liabilities  (as reported)172,747
Long-term Liabilities  (calculated)170,343
+/- 2,404
Total Stockholder Equity
Total Stockholder Equity (as reported)558,950
Total Stockholder Equity (calculated)0
+/- 558,950
Other
Capital Stock308
Common Stock Shares Outstanding 30,752
Net Invested Capital 558,950
Net Working Capital -331,303
Property Plant and Equipment Gross 344,794



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
1,072,329
1,143,071
1,137,634
1,222,134
1,296,142
1,390,677
1,451,360
1,469,708
1,577,143
1,659,935
1,344,346
1,315,453
1,328,425
1,352,495
1,395,723
1,406,938
1,486,721
1,656,828
1,656,8281,486,7211,406,9381,395,7231,352,4951,328,4251,315,4531,344,3461,659,9351,577,1431,469,7081,451,3601,390,6771,296,1421,222,1341,137,6341,143,0711,072,329
   > Total Current Assets 
250,397
317,028
303,002
319,082
395,005
473,651
533,380
550,100
641,220
690,912
355,969
328,887
337,741
333,962
367,622
378,927
448,881
593,828
593,828448,881378,927367,622333,962337,741328,887355,969690,912641,220550,100533,380473,651395,005319,082303,002317,028250,397
       Cash And Cash Equivalents 
79,290
131,920
133,999
160,903
219,227
277,766
332,877
339,009
398,387
461,304
82,843
42,551
31,007
28,265
46,922
39,138
95,207
245,449
245,44995,20739,13846,92228,26531,00742,55182,843461,304398,387339,009332,877277,766219,227160,903133,999131,92079,290
       Net Receivables 
113,931
155,662
136,374
127,286
134,087
160,962
159,997
161,489
186,378
186,432
224,759
225,695
249,086
264,704
257,746
275,058
292,773
275,932
275,932292,773275,058257,746264,704249,086225,695224,759186,432186,378161,489159,997160,962134,087127,286136,374155,662113,931
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
48,367
60,641
57,648
52,293
62,954
64,731
60,901
49,979
49,97960,90164,73162,95452,29357,64860,64148,3670000000000
   > Long-term Assets 
821,932
826,043
834,632
903,052
901,137
917,026
917,980
919,608
935,923
969,023
988,377
986,566
990,684
1,018,533
1,028,101
1,028,011
1,037,840
1,063,000
1,063,0001,037,8401,028,0111,028,1011,018,533990,684986,566988,377969,023935,923919,608917,980917,026901,137903,052834,632826,043821,932
       Property Plant Equipment 
0
99,444
108,682
179,520
181,005
198,826
196,770
196,925
213,131
222,711
240,167
238,927
243,790
248,917
257,064
254,680
258,911
265,390
265,390258,911254,680257,064248,917243,790238,927240,167222,711213,131196,925196,770198,826181,005179,520108,68299,4440
       Goodwill 
662,427
662,396
662,427
662,427
662,458
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396
662,396662,396662,396662,396662,396662,396662,396662,396662,396662,396662,396662,396662,396662,458662,427662,427662,396662,427
       Intangible Assets 
57,345
54,350
52,353
50,373
48,423
46,474
45,196
43,917
42,639
41,360
40,522
39,684
38,846
38,008
37,458
36,908
36,359
35,809
35,80936,35936,90837,45838,00838,84639,68440,52241,36042,63943,91745,19646,47448,42350,37352,35354,35057,345
       Long-term Assets Other 
5,673
9,477
10,680
10,263
8,774
8,794
13,062
15,830
16,485
17,422
19,483
19,118
18,629
21,129
22,026
22,261
20,831
24,970
24,97020,83122,26122,02621,12918,62919,11819,48317,42216,48515,83013,0628,7948,77410,26310,6809,4775,673
> Total Liabilities 
380,322
416,788
419,835
484,065
504,513
584,898
592,433
617,826
679,058
707,007
739,330
1,032,201
978,540
966,108
1,048,461
1,015,878
1,015,809
1,097,878
1,097,8781,015,8091,015,8781,048,461966,108978,5401,032,201739,330707,007679,058617,826592,433584,898504,513484,065419,835416,788380,322
   > Total Current Liabilities 
314,392
343,002
338,651
337,984
358,396
440,110
447,306
472,607
517,182
557,217
579,428
878,959
820,868
803,470
881,889
852,437
848,518
925,131
925,131848,518852,437881,889803,470820,868878,959579,428557,217517,182472,607447,306440,110358,396337,984338,651343,002314,392
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
249,700
139,700
50,000
115,000
55,000
0
0
0055,000115,00050,000139,700249,70000000000000
       Accounts payable 
20,684
22,404
16,985
14,879
15,878
26,552
21,348
23,326
25,052
25,678
25,434
28,800
28,245
33,069
37,110
33,608
29,023
31,869
31,86929,02333,60837,11033,06928,24528,80025,43425,67825,05223,32621,34826,55215,87814,87916,98522,40420,684
       Other Current Liabilities 
21,644
200,369
202,105
206,205
210,425
263,301
286,239
288,255
318,961
355,977
380,516
408,497
430,115
478,504
528,578
531,904
534,432
40,441
40,441534,432531,904528,578478,504430,115408,497380,516355,977318,961288,255286,239263,301210,425206,205202,105200,36921,644
   > Long-term Liabilities 
65,930
73,786
81,184
146,081
146,117
144,788
145,127
145,219
161,876
149,790
159,902
153,242
157,672
162,638
166,572
163,441
167,291
172,747
172,747167,291163,441166,572162,638157,672153,242159,902149,790161,876145,219145,127144,788146,117146,08181,18473,78665,930
       Capital Lease Obligations Min Short Term Debt
46,022
45,212
51,395
114,984
110,670
115,143
114,144
112,850
128,211
130,965
141,624
134,977
139,203
138,867
142,689
139,390
143,039
142,122
142,122143,039139,390142,689138,867139,203134,977141,624130,965128,211112,850114,144115,143110,670114,98451,39545,21246,022
       Long-term Liabilities Other 
14,330
15,725
15,767
15,756
15,586
16,094
16,107
16,127
16,061
17,745
17,223
17,263
17,558
22,701
22,793
22,953
23,124
28,221
28,22123,12422,95322,79322,70117,55817,26317,22317,74516,06116,12716,10716,09415,58615,75615,76715,72514,330
> Total Stockholder Equity
692,007
726,283
717,799
738,069
791,629
805,779
858,927
851,882
898,085
952,928
605,016
283,252
349,885
386,387
347,262
391,060
470,912
558,950
558,950470,912391,060347,262386,387349,885283,252605,016952,928898,085851,882858,927805,779791,629738,069717,799726,283692,007
   Common Stock
0
360
355
354
357
355
359
358
359
360
336
309
309
309
306
306
307
0
03073063063093093093363603593583593553573543553600
   Retained Earnings 
38,296
68,109
53,831
70,347
111,807
115,229
158,535
142,315
184,950
234,984
-120,812
-446,142
-380,115
-359,827
-408,099
-371,022
-300,197
-221,645
-221,645-300,197-371,022-408,099-359,827-380,115-446,142-120,812234,984184,950142,315158,535115,229111,80770,34753,83168,10938,296
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 0-12,870-11,194-11,314-12,392-16,052-9,972-6,388-4,846-3,243-1,760-2,266-131-2,123-3,223-3,729-2,7410



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,885,842
Cost of Revenue-1,361,337
Gross Profit524,505524,505
 
Operating Income (+$)
Gross Profit524,505
Operating Expense-1,549,017
Operating Income336,825-1,024,512
 
Operating Expense (+$)
Research Development-
Selling General Administrative161,352
Selling And Marketing Expenses-
Operating Expense1,549,017161,352
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-488
Net Interest Income-488
 
Pretax Income (+$)
Operating Income336,825
Net Interest Income-488
Other Non-Operating Income Expenses-
Income Before Tax (EBT)335,682337,480
EBIT - interestExpense = 0
282,810
282,810
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-335,682
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax335,682
Tax Provision-52,872
Net Income From Continuing Ops282,810282,810
Net Income282,810
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-655488
 

Technical Analysis of Medpace
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medpace. The general trend of Medpace is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medpace's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medpace Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 382.00 < 382.50.

The bearish price targets are: 358.40 > 356.00 > 284.50.

Tweet this
Medpace Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medpace Holdings Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medpace Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medpace Holdings Inc. The current macd is 4.24299988.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medpace price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Medpace. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Medpace price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Medpace Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartMedpace Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medpace Holdings Inc. The current adx is 25.99.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Medpace shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Medpace Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medpace Holdings Inc. The current sar is 376.54.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Medpace Holdings Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medpace Holdings Inc. The current rsi is 54.08. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Medpace Holdings Inc Daily Relative Strength Index (RSI) ChartMedpace Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medpace Holdings Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medpace price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Medpace Holdings Inc Daily Stochastic Oscillator ChartMedpace Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medpace Holdings Inc. The current cci is 40.30.

Medpace Holdings Inc Daily Commodity Channel Index (CCI) ChartMedpace Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medpace Holdings Inc. The current cmo is 2.5597661.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Medpace Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartMedpace Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medpace Holdings Inc. The current willr is -52.69709544.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Medpace is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Medpace Holdings Inc Daily Williams %R ChartMedpace Holdings Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Medpace Holdings Inc.

Medpace Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medpace Holdings Inc. The current atr is 7.02501216.

Medpace Holdings Inc Daily Average True Range (ATR) ChartMedpace Holdings Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medpace Holdings Inc. The current obv is -993.

Medpace Holdings Inc Daily On-Balance Volume (OBV) ChartMedpace Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medpace Holdings Inc. The current mfi is 57.53.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Medpace Holdings Inc Daily Money Flow Index (MFI) ChartMedpace Holdings Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medpace Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-30 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-19 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-08 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-16 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-19 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-14 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-06 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Medpace Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medpace Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.084
Ma 20Greater thanMa 50368.790
Ma 50Greater thanMa 100353.466
Ma 100Greater thanMa 200309.928
OpenGreater thanClose374.800
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medpace with someone you think should read this too:
  • Are you bullish or bearish on Medpace? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medpace? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medpace Holdings Inc

I send you an email if I find something interesting about Medpace Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Medpace Holdings Inc.

Receive notifications about Medpace Holdings Inc in your mailbox!